Huntington National Bank
GPCR icon

Huntington National Bank’s Structure Therapeutics GPCR Stock Holding History

Huntington National Bank’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.24K Buy
79
+77
+3,850% +$3.41K ﹤0.01% 2288
2026
Q1 		$96 Hold
2
– – ﹤0.01% 2615
2025
Q4 		$139 Hold
2
– – ﹤0.01% 2471
2025
Q3 		$56 Hold
2
– – ﹤0.01% 2838
2025
Q2 		$41 Hold
2
– – ﹤0.01% 3050
2025
Q1 		$35 Hold
2
– – ﹤0.01% 3170
2024
Q4 		$54 Hold
2
– – ﹤0.01% 2951
2024
Q3 		$88 Hold
2
– – ﹤0.01% 2756
2024
Q2 		$79 Buy
+2
New +$82 ﹤0.01% 2749

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Huntington National Bank's GPCR Position: Q2 2026 in Review

Huntington National Bank increased its Structure Therapeutics (GPCR) stake by 3,850% in Q2 2026, buying an estimated $3.41K and bringing the position to 79 shares worth $4.24K. The position accounts for ﹤0.01% of the portfolio, ranked #2288.

Huntington National Bank first reported a position in GPCR in Q2 2024 and has held it in 9 quarters since. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Huntington National Bank held 79 shares of Structure Therapeutics worth $4.24K as of Q2 2026.
  • Huntington National Bank bought 77 Structure Therapeutics shares in Q2 2026, an estimated $3.41K.
  • Structure Therapeutics made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #2288 holding.
  • Huntington National Bank first reported a position in Structure Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.